The challenges of providing renal replacement therapy in decompensated liver cirrhosis

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 144-148

  Gonwa, Thomas A ^a   Wadei, Hani M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Liver cirrhosis; Renal failure; Renal replacement therapy

Indexed keywords

BLOOD CLOTTING DISORDER; CONFERENCE PAPER; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC ACCURACY; EXTRACORPOREAL ALBUMIN DIALYSIS; HEMODIALYSIS; HYPOTENSION; INTRACRANIAL PRESSURE; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

HUMANS; KIDNEY; LIVER; LIVER CIRRHOSIS; PROGNOSIS; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY;

EID: 84856059822     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000334149     Document Type: Conference Paper

References (32)

1. Davis CL, Gonwa TA, Wilkinson AH: Patho-physiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl 2002; 8:91-109.
2. Gines P, Cardenas A, Arroyo V, Rodes J: Management of cirrhosis and ascites. N Engl J Med 2004; 350: 164 6-1654.
3. Wadei HM, Mai ML, Ahsan N, Gonwa TA: Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol 2006; 1:1066-1079.
4. Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP: Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998; 54: 518-52 4.
5. Cholongitas E, Calvaruso V, Senzolo M, Patch D, Shaw S, O'Beirne J, Burroughs AK: RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepa-tol 2009; 24:1639-1647.
6. Cholongitas E, Senzolo M, Patch D, Shaw S, O'Beirne J, Burroughs AK: Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroen-terol Hepatol 2009; 21:744-750.
7. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Will-ingham DL, Ahsan N, Gonwa TA: Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant 2008; 8: 2618-2626.
8. Martin-Llahi M, Guevara M, Torre A, Fa-gundes C, Restuccia T, Gilabert R, Sola E, Pereira G, Marinelli M, Pavesi M, Fernandez J, Rodes J, A rroyo V, Gines P: Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011; 140:488-496, e484.
9. Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ: Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 2005; 68:362-370.
10. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Klintmalm GB: Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation 1997; 64:1760-1765.
11. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N: Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transpla nt 2006; 6: 2651-2659.
12. Davis CL, Feng S, Sung R, Wong F, Goodrich NP, Melton LB, Reddy KR, Guidinger MK, Wilkinson A, Lake J: Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007; 7:1702-1709.
13. Ellis D, Avner ED: Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. Clin Nephrol 1986; 25: 295-303.
14. Wilkinson SP, Weston MJ, Parsons V, Williams R: Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 1977; 8:287-292.
15. Davenport A: Renal replacement therapy in the patient with acute brain injury. Am J Kid ney Dis 2001; 37: 457-466.
16. Davenport A, Bouman C, Kirpalani A, Skip-pen P, Tolwani A, Mehta RL, Palevsky PM: Delivery of renal replacement therapy in acute kidney injury: what are the key issues? Clin J Am Soc Nephrol 2008; 3:869-875.
17. Davenport A, Will EJ, Davidson AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328-338.
18. Davenport A, Will EJ, Davison AM: Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 1993; 41:S245-S251.
19. De Vriese AS, Colardyn FA, Philippe JJ, Van-holder RC, De Sutter JH, Lameire NH: Cyto-kine removal during continuous hemofiltra-tion in septic patients. J Am Soc Nephrol 1999; 10:846-853.
20. Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, R imola A, Arroyo V, Rodes J: Tumor necrosis factor and interleu-kin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatol-ogy 1998; 27:1227-1232.
21. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB: Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation 2001; 71: 1424-1428.
22. Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A: Which patients benefit from hemodialysis therapy in hepato-renal syndrome? J Gastroenterol Hepatol 2004; 19: 1369-1373.
23. Detry O, Arkadopoulos N, Ting P, Kahaku E, Margulies J, Arnaout W, Colquhoun SD, Rozga J, Demetriou AA: Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation 1999; 67:767-770.
24. Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Miloszewski KJ, Losow-sky MS: Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 1989; 53: 142-146.
25. Xia VW, Ghobrial RM, Du B, Chen T, Hu K-Q, Hiatt JR, Busuttil RW, Steadman RH: Predictors of hyperkalemia in the prereper-fusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007; 105: 780-785.
26. De Wolf A, Frenette L, Kang Y, Tang C: Insulin decreases the serum potassium concentration during the anhepatic stage of liver transplantation. Anesthesiology 1993; 78: 677-682.
27. Townsend DR, Bagshaw SM, Jacka MJ, Bi-gam D, Cave D, Gibney RT: Intraoperative renal support during liver transplantation. Liver Transpl 2009; 15:73-78.
28. Cerda J, Tolwani A, Gibney N, Tiranathana-gul K: Renal replacement therapy in special settings: extracorporeal support devices in liver failure. Semin Dial 2011; 24: 197-202.
29. Mitzner SR, Klammt S, Peszynski P, Hick-stein H, Korten G, Stange J, Schmidt R: Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 2001; 5:417-422.
30. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277-286.
31. Khuroo MS, Farahat KL: Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analy-sis. Liver Transpl 2004; 10:1099-1106.
32. Wong F, Raina N, Richardson R: Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with as-cites who have failed vasoconstrictor treatment. Gut 2010; 59: 381-386.